Literature DB >> 25110333

Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.

Bohdan Nosyk1, Libo Li2, Elizabeth Evans2, Darren Urada2, David Huang2, Evan Wood3, Richard Rawson2, Yih-Ing Hser2.   

Abstract

BACKGROUND: California treats the largest population of opioid dependent individuals in the USA and is among a small group of states that applies regulations for opioid treatment that are more stringent than existing federal regulations. We aim to characterize changes in patient characteristics and treatment utilization over time, and identify determinants of successful completion of detoxification and MMT retention in repeated attempts.
METHODS: State-wide administrative data was obtained from California Outcome Measurement System during the period: January 1st, 1991-March 31st, 2012. Short-term detoxification treatment and long-term maintenance treatment, primarily with methadone, was available to study participants. Mixed effects regression models were used to define determinants of successful completion of the detoxification treatment protocol (as classified by treatment staff) and duration of maintenance treatment.
RESULTS: The study sample consisted of 237,709 unique individuals and 885,971 treatment episodes; 837% were detoxification treatment episodes in 1994, dropping to 40.5% in 2010. Among individuals accessing only detoxification, the adjusted odds of success declined with each successive attempt (vs. 1st attempt: 2nd: OR: 0.679; 95% CI (0.610, 0.755); 3rd: 0.557 (0.484, 0.641); 4th: 0.526 (0.445, 0.622); 5th: 0.407 (0.334, 0.497); ≥6th: 0.339 (0.288, 0.399). For those ever accessing maintenance treatment, later subsequent attempts were longer in duration, and those with two or more prior attempts at detoxification had marginally longer subsequent maintenance episodes (hazard ratio: 0.97; 95% CI: 0.95, 0.99). Finally, only 10.9% of all detoxification episodes were followed by admission into maintenance treatment within 14 days.
CONCLUSIONS: This study has revealed high rates of detoxification treatment for opioid dependence in California throughout the study period, and decreasing odds of success in repeated attempts at detoxification.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Detoxification treatment; Longitudinal; Methadone treatment; Opioid dependence

Mesh:

Substances:

Year:  2014        PMID: 25110333      PMCID: PMC4484858          DOI: 10.1016/j.drugalcdep.2014.07.020

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  23 in total

1.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

2.  Benefits and costs of methadone treatment: results from a lifetime simulation model.

Authors:  Gary A Zarkin; Laura J Dunlap; Katherine A Hicks; Daniel Mamo
Journal:  Health Econ       Date:  2005-11       Impact factor: 3.046

3.  Methods of detoxification and their role in treating patients with opioid dependence.

Authors:  Patrick G O'Connor
Journal:  JAMA       Date:  2005-08-24       Impact factor: 56.272

4.  Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs.

Authors:  Christina M Andrews; Thomas A D'Aunno; Harold A Pollack; Peter D Friedmann
Journal:  Med Care Res Rev       Date:  2013-09-18       Impact factor: 3.929

5.  Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.

Authors:  Einat Peles; Shaul Schreiber; Miriam Adelson
Journal:  Drug Alcohol Depend       Date:  2005-10-10       Impact factor: 4.492

Review 6.  An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.

Authors:  Laura Amato; Marina Davoli; Carlo A Perucci; Marica Ferri; Fabrizio Faggiano; Richard P Mattick
Journal:  J Subst Abuse Treat       Date:  2005-06

7.  Limit setting on drug abuse in methadone maintenance patients.

Authors:  J J McCarthy; O T Borders
Journal:  Am J Psychiatry       Date:  1985-12       Impact factor: 18.112

Review 8.  Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.

Authors:  L Amato; S Minozzi; M Davoli; S Vecchi; M Ferri; S Mayet
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

Review 9.  Methadone maintenance at different dosages for opioid dependence.

Authors:  F Faggiano; F Vigna-Taglianti; E Versino; P Lemma
Journal:  Cochrane Database Syst Rev       Date:  2003

10.  Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities.

Authors:  Andrew Rosenblum; Herman Joseph; Chunki Fong; Steven Kipnis; Charles Cleland; Russell K Portenoy
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  12 in total

1.  Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.

Authors:  Elizabeth Evans; Libo Li; Jeong Min; David Huang; Darren Urada; Lei Liu; Yih-Ing Hser; Bohdan Nosyk
Journal:  Addiction       Date:  2015-03-15       Impact factor: 6.526

Review 2.  Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review.

Authors:  Salva N Balbale; Itishree Trivedi; Linda C O'Dwyer; Megan C McHugh; Charlesnika T Evans; Neil Jordan; Laurie A Keefer
Journal:  Dig Dis Sci       Date:  2017-08-05       Impact factor: 3.199

3.  Short term health-related quality of life improvement during opioid agonist treatment.

Authors:  B Nosyk; J W Bray; E Wittenberg; B Aden; A A Eggman; R D Weiss; J Potter; A Ang; Y-I Hser; W Ling; B R Schackman
Journal:  Drug Alcohol Depend       Date:  2015-10-25       Impact factor: 4.492

4.  Opioid Use in the Twenty First Century: Similarities and Differences Across National Borders.

Authors:  Georgi Vasilev; Svetla Milcheva; Jasmin Vassileva
Journal:  Curr Treat Options Psychiatry       Date:  2016-07-09

5.  The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.

Authors:  Emanuel Krebs; Darren Urada; Elizabeth Evans; David Huang; Yih-Ing Hser; Bohdan Nosyk
Journal:  Addiction       Date:  2017-02-06       Impact factor: 6.526

6.  Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities.

Authors:  Ramin Mojtabai; Christine Mauro; Melanie M Wall; Colleen L Barry; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2019-01       Impact factor: 6.301

7.  Estimating State Transitions for Opioid Use Disorders.

Authors:  Emanuel Krebs; Jeong E Min; Elizabeth Evans; Libo Li; Lei Liu; David Huang; Darren Urada; Thomas Kerr; Yih-Ing Hser; Bohdan Nosyk
Journal:  Med Decis Making       Date:  2016-12-27       Impact factor: 2.583

8.  Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder.

Authors:  Elizabeth A Evans; Caroline Yoo; David Huang; Andrew J Saxon; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2019-08-07

9.  Gender differences in mortality among treated opioid dependent patients.

Authors:  E Evans; A Kelleghan; L Li; J Min; D Huang; D Urada; Y I Hser; B Nosyk
Journal:  Drug Alcohol Depend       Date:  2015-07-17       Impact factor: 4.492

Review 10.  Treatment of opioid dependence with buprenorphine: current update.

Authors:  Michael Soyka
Journal:  Dialogues Clin Neurosci       Date:  2017-09       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.